Crossmark

Long term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer

Crossref DOI link: https://doi.org/10.1186/s12885-019-5542-3

Published Online: 2019-04-03

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sumodhee, Shakeel

Bondiau, Pierre-Yves

Poudenx, Michel

Cohen, Charlotte

Naghavi, Arash O.

Padovani, Bernard

Maneval, Daniel

Gal, Jocelyn

Leysalle, Axel

Ghalloussi, Hannah

Otto, Josiane

Doyen, Jérôme
License Information

Text and Data Mining valid from 2019-04-03
More Information

Article History

Received: 18 February 2019

Accepted: 28 March 2019

First Online: 3 April 2019

Ethics approval and consent to participate

: Our protocol was approved by the Institutional Review Board of Antoine Lacassagne Cancer Centre (MR001) which approved the ethical aspect of the protocol. The board waived the requirement for informed consents because this study was retrospective.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.